Home

Guardian Pharmacy Services, Inc. Class A Common Stock (GRDN)

23.98
-0.22 (-0.91%)
NYSE · Last Trade: Apr 28th, 1:01 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Earnings Scheduled For March 26, 2025benzinga.com
Via Benzinga · March 26, 2025
Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 3, 2024
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 2, 2024
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Sessionaecom
Via Benzinga · November 19, 2024
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Ratingbenzinga.com
Truist initiates coverage of Guardian Pharmacy, projecting a $22 price target due to strong growth in the $24.8 billion institutional pharmacy market.
Via Benzinga · October 21, 2024
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · October 21, 2024
Self-Driving Startup Pony.ai Files For U.S. IPOtalkmarkets.com
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group -- saw their stocks open for trading.
Via Talk Markets · October 20, 2024
Obesity Drug Developer BioAge Makes Nasdaq Debuttalkmarkets.com
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials.
Via Talk Markets · September 29, 2024